Purpose: The aims of this study were to determine the prevalence of vitreomacular adhesion (VMA) in a random sample of clinical patients at three US retina clinics and to assess comorbid retinal conditions, ocular diseases, prior treatment history, and other medical histories. All other authors have declared no conflicts of interest.Elias Reichel, 1 Glenn J Jaffe, 2 Srinivas R Sadda, 3 Stefanie Schuman, 2 Amir H Hariri, 3 Keegan Skidmore, 1 Jake Duker 1ġDepartment of Ophthalmology, New England Eye Center, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, 2Duke Eye Center, Duke Reading Center, Durham, NC, 3Department of Ophthalmology, Doheny Eye Centers, University of California, Los Angeles, CA, USA

Salgado: Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Roche Advisory/Consultancy: Bristol-Myers Squibb Research grant/Funding (self), Travel/Accommodation/Expenses: Merck Research grant/Funding (self): Puma Biotechnology Travel/Accommodation/Expenses: AstraZeneca. Linn: Research grant/Funding (self): ZonMw Research grant/Funding (self): A Sister's Hope Advisory/Consultancy, Research grant/Funding (institution), Non-remunerated activity/ies, institutional non-financial support: AstraZeneca Advisory/Consultancy, Non-remunerated activity/ies, institutional non-financial support: Cergentis Advisory/Consultancy, Non-remunerated activity/ies, institutional non-financial support: IBM Advisory/Consultancy, Research grant/Funding (institution): Pfizer Advisory/Consultancy, Research grant/Funding (institution), Non-remunerated activity/ies, institutional non-financial support: Roche-Genentech Research grant/Funding (institution), Non-remunerated activity/ies, institutional non-financial support: Tesaro Research grant/Funding (institution), Non-remunerated activity/ies, institutional non-financial support: immunomedics Non-remunerated activity/ies: Bayer Research grant/Funding (institution), institutional non-financial support: Agendia Research grant/Funding (institution): Eurocept-pharmaceuticals Research grant/Funding (institution): Novartis. Kok: Advisory/Consultancy, Research grant/Funding (institution): Bristol-Meyers Squibb Research grant/Funding (institution): Roche-Genentech Research grant/Funding (institution): AstraZeneca Advisory/Consultancy: Daiichi Sankyo. Loi: Advisory/Consultancy, Research grant/Funding (institution): Novartis Advisory/Consultancy, Research grant/Funding (institution): Bristol-Meyers Squibb Advisory/Consultancy, Research grant/Funding (institution): Merck Advisory/Consultancy, Research grant/Funding (institution): Roche-Genentech Research grant/Funding (institution): Puma Biotechnology Advisory/Consultancy, Research grant/Funding (institution): Pfizer Research grant/Funding (institution): Eli Lilly Advisory/Consultancy, Research grant/Funding (institution): Seattle Genetics Advisory/Consultancy: AstraZeneca Advisory/Consultancy: Aduro Biotech Advisory/Consultancy: GlaxoSmithKline Advisory/Consultancy: G1 Therapeutics.

Michiels: Advisory/Consultancy, Statistical advice: IDDI Advisory/Consultancy, Statistical advice: Janssen Advisory/Consultancy, Statistical advice: Cilag Advisory/Consultancy, Independant Data Monitoring Committee: Hexal Advisory/Consultancy, Independent Data Monitoring Committee: Steba Advisory/Consultancy, Independent Data Monitoring Committee: IQVIA Advisory/Consultancy, Independent Data Monitoring Committee: Roche Advisory/Consultancy, Independent Data Monitoring Committee: Sensorion Advisory/Consultancy, Independent Data Monitoring Committee: Biophytis Advisory/Consultancy, Independent Data Monitoring Committee: Servier Advisory/Consultancy, Independent Data Monitoring Committee: Yuhan.

Vmt medical